NWBO - NORTHWEST BIOTHERAPEUTICS INC -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
NORTHWEST BIOTHERAPEUTICS INC
IPO Date: January 1, 2002
Sector: Healthcare
Industry: Biotech
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.12 | 4.36%
Avg Daily Range (30 D): $0.01 | 4.82%
Avg Daily Range (90 D): $0.01 | 5.42%
Institutional Daily Volume
Avg Daily Volume: 1.09M
Avg Daily Volume (30 D): 3.38M
Avg Daily Volume (90 D): 3.12M
Trade Size
Avg Trade Size (Sh.): 1,252
Avg Trade Size (Sh.) (30 D): 9,740
Avg Trade Size (Sh.) (90 D): 8,768
Institutional Trades
Total Institutional Trades: 49
Avg Institutional Trade: $1.47M
Avg Institutional Trade (30 D): $.55M
Avg Institutional Trade (90 D): $.55M
Avg Institutional Trade Volume: .33M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.47M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 617.26K
 
News
Apr 30, 2026 @ 4:30 PM
Northwest Biotherapeutics Appoints Dr. Annalisa Je...
Source: Prnewswire
Apr 21, 2026 @ 1:30 PM
Northwest Biotherapeutics Announces Establishment ...
Source: Prnewswire
Oct 24, 2025 @ 4:03 PM
Northwest Biotherapeutics Announces That Its Acqui...
Source: Prnewswire
Aug 27, 2025 @ 4:39 PM
Northwest Biotherapeutics Announces Agreement to A...
Source: Prnewswire
Financials
  TTM Q4 2024 Q1 2024
Basic EPS $-.03 $-.02 $-.02
Diluted EPS $-.03 $-.02 $-.02
Revenue $2.17M $.23M $.28M
Gross Profit
Net Income / Loss $-154.75M $-28.2M $-18.3M
Operating Income / Loss $-50.33M $-18.5M $-15.74M
Cost of Revenue
Net Cash Flow $-8.35M $-4.32M $-.56M
PE Ratio    
Splits
Sep 26, 2012 1:16
Jun 28, 2007 1:15